Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

EPT Disclosure

17 Oct 2008 09:24

RNS Number : 0860G
Liberum Capital Limited
17 October 2008
Ā 

Ā 

DEALINGS BYĀ CONNECTED EXEMPT PRINCIPAL TRADERSĀ 

WITHOUTĀ RECOGNISEDĀ INTERMEDIARY STATUS, OR WITH RI STATUS

BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

(RuleĀ 38.5(b)Ā ofĀ the TakeoverĀ Code)

1. KEY INFORMATION

Name ofĀ exempt principal trader

Liberum Capital Limited

Ā 

Company dealt in

Flying Brands

Ā 

Class of relevant security to which the dealings being disclosed relateĀ (NoteĀ 1)

Ā 

Units comprising 1 ordinary 1p share and 1Ā AĀ ordinaryĀ ofĀ 0.005p share

Date of dealing

16/10/08

Ā 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) InterestsĀ and short positionsĀ (following dealing) in the class of relevant security dealt inĀ (NoteĀ 2)

Long

Short

Number (%)

Number (%)

(1) Relevant securitiesĀ 

36,488 0.144%

0 0%

(2) DerivativesĀ (other than options)

(3)Ā OptionsĀ and agreements to purchase/sell

Total

36,488 0.144%

0 0%

(b) InterestsĀ and short positionsĀ in relevant securities of the company, other than theĀ classĀ dealt inĀ (NoteĀ 2)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(1) Relevant securitiesĀ 

(2) DerivativesĀ (other than options)

(3)Ā OptionsĀ and agreements to purchase/sell

Total

Rights to subscribeĀ (NoteĀ 2)

Class of relevant security:

Details

3. DEALINGSĀ (Note 3)

(a) Purchases and sales

Purchase/sale

Number of securities

Price per unitĀ (NoteĀ 4)

Purchase

10,000

0.42p

Sell

0

0

(b) Derivatives transactions (other than options)

Product name,Ā 

e.g. CFD

Long/shortĀ (NoteĀ 5)

Number of securitiesĀ (NoteĀ 6)

Price per unitĀ (NoteĀ 4)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g.Ā callĀ option

Writing, selling, purchasing, varying etc.

Number of securitiesĀ to which the option relatesĀ (NoteĀ 6)

Exercise

priceĀ 

Type,Ā e.g. American, European etc.

ExpiryĀ 

date

Option money

paid/receivedĀ per unitĀ (NoteĀ 4)Ā 

(ii) Exercising

Product name,Ā e.g.Ā call option

Number of securitiesĀ 

Exercise priceĀ per unitĀ (NoteĀ 4)

(d) Other dealings (including new securities)Ā (NoteĀ 3)

Nature of transactionĀ (NoteĀ 7)

Details

PriceĀ per unitĀ (if applicable)Ā (NoteĀ 4)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form orĀ relating to the voting rights orĀ future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental FormĀ 38.5(b)Ā attached?Ā (NoteĀ 8) NO

Date of disclosure

17/10/08

Ā 

Contact name

Carl ChambersĀ 

Ā 

Telephone number

020 3100 2000

Ā 

Name of offeree/offeror with which connected

West Coast Capital

Ā 

NatureĀ of connectionĀ (NoteĀ 9)

Adviser

Ā 

Notes

The Notes on FormĀ 38.5(b)Ā can be viewed on the Takeover Panel's websiteĀ atĀ www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
EMMFFDSAWSASEES
Date   Source Headline
2nd Sep 20217:00 amRNSBoard Changes
1st Sep 202110:00 amRNSStart of Trading on the OTCQB Venture Market
27th Aug 20219:57 amRNSHalf Yearly Report
11th Jun 20214:41 pmRNSSecond Price Monitoring Extn
11th Jun 20214:36 pmRNSPrice Monitoring Extension
11th Jun 20212:05 pmRNSSecond Price Monitoring Extn
11th Jun 20212:00 pmRNSPrice Monitoring Extension
11th Jun 202111:05 amRNSSecond Price Monitoring Extn
11th Jun 202111:00 amRNSPrice Monitoring Extension
11th Jun 20218:00 amRNSIQAI Awarded “Gad-Free” Patent
4th Jun 20217:00 amRNSIB Software Chosen by LA County Hospital
19th May 202112:06 pmRNSResult of AGM
27th Apr 20213:27 pmRNSNotice of AGM
20th Apr 202110:21 amRNSFinal Results
16th Apr 20214:41 pmRNSSecond Price Monitoring Extn
16th Apr 20214:36 pmRNSPrice Monitoring Extension
13th Apr 20217:27 amRNSIQAI commits to Phase 1 study
6th Apr 20217:00 amRNSFive Year NCI Award Grant to IB
5th Feb 20214:41 pmRNSSecond Price Monitoring Extn
5th Feb 20214:36 pmRNSPrice Monitoring Extension
5th Feb 20212:05 pmRNSSecond Price Monitoring Extn
5th Feb 20212:01 pmRNSPrice Monitoring Extension
5th Feb 20219:05 amRNSSecond Price Monitoring Extn
5th Feb 20219:00 amRNSPrice Monitoring Extension
28th Jan 20217:00 amRNS"Gad Free" Imaging Update
25th Jan 202111:01 amRNSPrice Monitoring Extension
14th Jan 20217:00 amRNSTechnology Portfolio Update
7th Jan 20212:06 pmRNSSecond Price Monitoring Extn
7th Jan 20212:00 pmRNSPrice Monitoring Extension
31st Dec 202012:41 pmRNSSecond Price Monitoring Extn
31st Dec 202012:36 pmRNSPrice Monitoring Extension
31st Dec 202011:00 amRNSPrice Monitoring Extension
10th Dec 202010:41 amRNSDirector Dealing and CLN Conversion - Correction
9th Dec 20202:05 pmRNSSecond Price Monitoring Extn
9th Dec 20202:01 pmRNSPrice Monitoring Extension
9th Dec 20209:02 amRNSDirector Dealing and Conversion of Loan Notes
7th Dec 202011:25 amRNSDirector Dealing
4th Dec 20204:52 pmRNSIssue of shares to Mayo Clinic
3rd Dec 20207:01 amRNSRelease of StoneChecker 20.12
26th Nov 20207:00 amRNSIMAGING BIOMETRICS UPGRADES IB CLINIC™ SOFTWARE
23rd Nov 20204:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20204:36 pmRNSPrice Monitoring Extension
23rd Nov 20202:06 pmRNSSecond Price Monitoring Extn
23rd Nov 20202:00 pmRNSPrice Monitoring Extension
23rd Nov 20201:45 pmRNSLSN Software is now CE Mark Approved
23rd Nov 202011:06 amRNSSecond Price Monitoring Extn
23rd Nov 202011:00 amRNSPrice Monitoring Extension
20th Nov 202011:05 amRNSSecond Price Monitoring Extn
20th Nov 202011:00 amRNSPrice Monitoring Extension
20th Nov 20209:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.